Compare DexCom, Inc. (DXCM) vs Super Micro Computer Inc (SMCI) Price & Performance

DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.

The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.

Super Micro Computer (SMCI) trades at $25.095, down 9.24% amid a broader AI hardware stock selloff. The stock shows bearish technical signals with support at $24 and faces fundamental challenges despite recent earnings beats. Revenue grew to $21.97B in 2025 but profit margins compressed to 3.7%. The company faces inventory buildup and cash flow strain while navigating a Taiwan export probe and intense AI competition.

SMCI presents a mixed outlook with attractive valuation metrics (P/E 14.15, P/S 0.53) but significant execution risks. Analyst consensus targets $36.71 (44% upside) with 36% buy ratings, though technical indicators remain bearish. Key risks include working capital pressure, margin compression, and regulatory scrutiny that could limit near-term performance despite long-term AI infrastructure growth potential.